Abstract OBJECTIVE: To study the molecular mechanism of apoptosis of leukemic cells (K562 cells) induced by iron chelating agent deferoxamine (DFO). METHODS: The exponentially growing K562 cells were used (1×106/mL) in this study. The K562 cells were treated with different concentrations of DFO (10, 50 and 100 mmol/L), DFO+FeCl3 (10 μmol/L each) or normal saline (blank control). The cellular labile iron pool was measured with a fluorimetric assay using the metalsensitive probe calcein-AM. The viable count and cell viability were determined by typanblue assay. Cell apoptosis was determined by morphological study and flow cytometry assay. Caspase-3 activity in K562 cells was detected by colorimetry. RESULTS: After DFO treatment, the cellular labile iron pool and the viability of K562 cells were reduced and the cell apoptosis increased in a time- and dose-dependent manner compared with the blank control group. The apoptosis rate of K562 cells in the DFO+FeCl3 treatment group was not significantly different from that in the blank control group. The caspase-3 activity in K562 cells increased significantly 24 hrs after 50 and 100 μmmol DFO treatment when compared with the blank control group (P<0.01). There was a negative correlation between cellular labile iron pool and caspase-3 activity of K562 cells (r=-0.894, P<0.05). CONCLUSIONS: DFO induces apoptosis of leukemic cells possibly through decreasing cellular labile iron pool and increasing caspase-3 activity of the cells.
［2］Meggiato T, Calabrese F, De Cesare CM, Baliello E, Valente M, Del Favero G. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death［J］. Pancreas, 2003, 26(1):65-70.
［3］Gao J, Lovejoy D, Richardson DR.Effect of iron chelators with potent anti-proliferative activity on the expression of molecules involved in cell cycle progression and growth［J］. Redox Rep, 1999, 4(6): 311-322.
［4］Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik I. Fluorescence analysis of the labile iron pool of mammalian cells［J］. Anal Biochem,1997, 248(1): 31-40.
［6］Greene BT, Thorburn J, Willingham MC, Thorburn A, Planalp RP, Brechbiel MW, et al. Activation of Caspase pathways during Iron Chelator-mediated Apoptosis［J］. Biol Chem, 2002, 277(28): 25568-25575.
［7］Roy S, Bayly CI, Gareau Y, Houtzager VM, Kargman S, Keen SL, et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide［J］. Proc Natl Acad Sci U S A, 2001, 22(11):6132-6137.
